Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in
Job Title: Senior Principal Scientist I, Translational Disease Biology Location : Vitry-sur-Seine – France About the job As Senior Principal Scientist I within the Biological Insights & Integration (BII) cluster in Target, Disease and Systems Biology
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in
— About Eligo — Eligo Bioscience, backed by top-tier investors from Silicon Valley and Europe, is pioneering next-generation microbiome therapeutics. Co-founded by MIT and Rockefeller University scientists, Eligo is headquartered in Paris, France. Our mission is
Scientist – Transgenic Models & Laboratory Digitalization Montpellier, France About the Job As a Scientist – Transgenic Models & Laboratory Digitalization within our Translational In Vivo Models (TIM) department, you will combine extensive hands‑on expertise in
AI Research Scientist – Biological Foundation Models Paris (hybrid) | €80,000–€100,000 + equity We’re partnering with an innovative deeptech company at the forefront of AI-driven drug discovery in immunology . Their mission is to tackle one
Scientist – Transgenic Models & Laboratory Digitalization Montpellier, France About the Job As a Scientist – Transgenic Models & Laboratory Digitalization within our Translational In Vivo Models (TIM) department, you will combine extensive hands‑on expertise in
2 days ago Be among the first 25 applicants Headquartered in Silicon Valley, we are a newly established start-up where a collective of visionary scientists, engineers, and entrepreneurs are dedicated to transforming the landscape of biology
About Us Spore.Bio is a deeptech startup founded in 2023 that is redefining microbiological quality control in pharmaceutical, food & beverage, and cosmetics manufacturing. Where Spore.Bio deploys biophotonic and deep-learning technology on factory floors, Spore.Labs takes